Alexander Vasilievich Ivashchenko

This inventor holds 9 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 6 EPO patents. Top assignees: Avincuro Pharmaceuticals, Inc., Other. Active years: 2012-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexander Vasilievich Ivashchenko. Retrieved from https://idiyas.com/inventor/alexander-vasilievich-ivashchenko

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 3)

% Patents Active = 11.1

CIPO Patents = 1

EPO Patents = 6 (Patent Applications = 11)

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 13(Granted Patents)

Location History:

Calle Rancho Vista, CA (US) (2012)
Encinitas, CA (2013)
Encinitas, CA (US) (2013 - 2014)

Company Filing History:

1 out of 1

Avincuro Pharmaceuticals, Inc.

patent

8 out of 834,570

Other

patents

Years Active: 2012-2014

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8629154 - Substituted cycloalcano[e and d] pyrazolo [1,5-a]pyrimidines/antagonists of serotonin 5-HT6 receptors and methods for production and the use thereof (2014-01-14),

2. 8618114 - Substituted 3-arylsulfonyl-pyrazolo[1,5-A]pyrimidines, serotonin 5-HT6 receptor antagonists and methods for the production and use thereof (2013-12-31),

3. 8569318 - Tetrahydro-pyrazolo[1,5-a]pyrido-pyrimidines as antagonists of serotonin 5-HT6 receptors, methods for the production and use thereof (2013-10-29),

4. 8552017 - 2-amino-3-sulphonyl-tetrahydro-pyrazolo[1,5-A]pyrido-pyrimidine antagonists of serotonin 5-HT6 receptors, methods for the production and use thereof (2013-10-08),

5. 8552005 - [object Object] (2013-10-08),

6. 8486945 - Heterocyclic inhibitors of an Hh-signal cascade, medicinal compositions based thereon and methods for treating diseases caused by the aberrant activity of an Hh-signal system (2013-07-16),

7. 8481587 - Substituted 2-(5-hydroxy-2-methyl-1H-indole-3-yl)acetic acids and ethers thereof and the use of same to treat viral diseases (2013-07-09),

8. 8471009 - (EN) 2-alkylamino-3-arylsulfonyl-cycloalcano [e OR d] pyrazolo [1,5-A]pyrimidines / antagonists of serotonin 5-HT6 receptors, methods for the production and the use thereof (2013-06-25),

9. 8309559 - (EN) substituted 2-amino-3-sulfonyl-pyrazolo[1,5-A] pyrimidines/antagonists of serotonin 5-HT6 receptors, methods for the production and the use thereof (2012-11-13),

Alexander Vasilievich Ivashchenko: Innovator in Pharmacology

Introduction

Alexander Vasilievich Ivashchenko is a prominent inventor based in Encinitas, California. With an impressive portfolio that includes nine patents, he has made significant contributions to the field of pharmacology, particularly in the development of novel therapeutic agents targeting serotonin receptors.

Latest Patents

Among his latest patents, Ivashchenko has developed substituted cycloalcano[e and d] pyrazolo[1,5-a]pyrimidines, which function as antagonists of serotonin 5-HT6 receptors. This invention relates to the development of new drug substances and pharmaceutical compositions that include these compounds as active ingredients. These advancements hold the potential to address various central nervous system (CNS) diseases in humans and warm-blooded animals, especially those associated with 5-HT6 receptor dysfunction.

Another significant patent relates to substituted 3-arylsulfonyl-pyrazolo[1,5-A]pyrimidines. This invention introduces novel pharmaceutical compositions designed for the prophylaxis and treatment of CNS diseases such as Alzheimer's disease, Parkinson's disease, and schizophrenia. It underscores the impact of serotonin 5-HT receptors in neurodegenerative diseases and cognitive disorders, including obesity.

Career Highlights

Throughout his career, Alexander Vasilievich Ivashchenko has collaborated with noteworthy companies, including Avincuro Pharmaceuticals, Inc. His work focuses on translating innovative chemical structures into effective therapeutic agents, showcasing his ability to bridge the gap between laboratory research and practical medical applications.

Collaborations

Working alongside esteemed individuals such as Nikolay Filippovich Savchuk and Andrey Alexandrovich Ivashchenko, he has fostered an environment of collaboration that drives advancements in pharmaceutical research. These partnerships have not only enhanced the quality of his inventions but have also contributed to the broader scientific community's understanding of CNS disorders.

Conclusion

Alexander Vasilievich Ivashchenko stands out as a key innovator in the pharmacological landscape. His contributions, particularly in developing compounds targeting serotonin receptors, reflect a commitment to improving therapeutic interventions for central nervous system diseases. As research continues to evolve, Ivashchenko's inventions are set to play a pivotal role in the future of medicine.

Profile summary based on public USPTO records.